Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

Phase 3CompletedNCT03517358

University of California, Davis10 enrolled

Overview

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Hiv

Interventions

Service of careOTHER

Subjects will be receiving care from case management or clinical pharmacy.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a baseline viral load \> 200 copies/ml * Patients who agree to program enrollment * Patients ≥ 18 years of age Exclusion Criteria: * Pregnant women * Adults unable to consent * Prisoners

Locations (1)

One Community Health

Sacramento, California, United States

Outcomes

Primary Outcomes

Percentage of virological suppression

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.